Invasive group A Streptococcus in Newfoundland and Labrador: Recent epidemiology and risk factors for severe infection

Background: This project aimed to describe the local epidemiology of invasive group A Streptococcus (iGAS) in Newfoundland and Labrador (NL) over the past 10 years, confirm suspicions of a provincial outbreak in 2024, and assess risk factors that may account for this outbreak.Methods: A retrospective chart review of a cohort of patients in NL with iGAS infection between January 1, 2015 and December 31, 2024 was conducted.Once an outbreak was confirmed through assessment of case counts over time, reference genotyping of cases and patient risk factor data were collected.Multivariate logistic regression was performed to compare patients within the outbreak period to the rest of the cohort and describe trends in infections across the province.Invasive group A Streptococcus rates were compared with publicly available provincial influenza A rates.Results: A total of 231 iGAS isolates from 199 patients met the inclusion criteria.Mean age was 49 years and 42.2% of patients were female.The background yearly incidence rate ranged from 0.94-4.36cases per 100,000 population per year.There was a significant outbreak from December 2023 to May 2024, with an incidence rate of 10.95 cases per 100,000 population per year.When comparing cases within (n=59) and outside (n=140) this outbreak period, there was a higher proportion of critical care admissions (39.0%[n=23] vs 16.4% [n=23], p=0.001) and higher proportional mortality (13.6% [n=8] vs 7.9% [n=11], p=0.147).There were no demographic or clinical risk factor differences between the pre-and post-outbreak groups.However, 57.6% (n=34) of epidemic cases were caused by emm1, compared to 28.6% (n=40) cases during the non-epidemic period (p<0.01).The emm1 type (odds ratio=2.620,p=0.010) was a significant predictor of critical care admission.Close correlations with provincial influenza rates are noted.Conclusion: A period of increased iGAS prevalence was defined, denoting an outbreak and association with the emm1 genotype.Respiratory infections such as influenza A played a likely role.

Authors

Institutions

Publication Details

Journal
Canada Communicable Disease Report
Published
2026-11-12
DOI
https://doi.org/10.14745/ccdr.v52i11a04
Primary Topic
Streptococcal Infections and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Invasive group A Streptococcus in Newfoundland and Labrador: Recent epidemiology and risk factors for severe infection

Theerawat Pongnopparat, Matthew Nelder, Peter Daley, Nessika Eilersen et al.
Canada Communicable Disease Report
Streptococcal Infections and Treatments
article

Invasive group A Streptococcus in Newfoundland and Labrador: Recent epidemiology and risk factors for severe infection

Theerawat Pongnopparat, Matthew Nelder, Peter Daley, Nessika Eilersen, Robert Taylor, John D Cullen
article en

Abstract

Background: This project aimed to describe the local epidemiology of invasive group A Streptococcus (iGAS) in Newfoundland and Labrador (NL) over the past 10 years, confirm suspicions of a provincial outbreak in 2024, and assess risk factors that may account for this outbreak.Methods: A retrospective chart review of a cohort of patients in NL with iGAS infection between January 1, 2015 and December 31, 2024 was conducted.Once an outbreak was confirmed through assessment of case counts over time, reference genotyping of cases and patient risk factor data were collected.Multivariate logistic regression was performed to compare patients within the outbreak period to the rest of the cohort and describe trends in infections across the province.Invasive group A Streptococcus rates were compared with publicly available provincial influenza A rates.Results: A total of 231 iGAS isolates from 199 patients met the inclusion criteria.Mean age was 49 years and 42.2% of patients were female.The background yearly incidence rate ranged from 0.94-4.36cases per 100,000 population per year.There was a significant outbreak from December 2023 to May 2024, with an incidence rate of 10.95 cases per 100,000 population per year.When comparing cases within (n=59) and outside (n=140) this outbreak period, there was a higher proportion of critical care admissions (39.0%[n=23] vs 16.4% [n=23], p=0.001) and higher proportional mortality (13.6% [n=8] vs 7.9% [n=11], p=0.147).There were no demographic or clinical risk factor differences between the pre-and post-outbreak groups.However, 57.6% (n=34) of epidemic cases were caused by emm1, compared to 28.6% (n=40) cases during the non-epidemic period (p<0.01).The emm1 type (odds ratio=2.620,p=0.010) was a significant predictor of critical care admission.Close correlations with provincial influenza rates are noted.Conclusion: A period of increased iGAS prevalence was defined, denoting an outbreak and association with the emm1 genotype.Respiratory infections such as influenza A played a likely role.

Canada Communicable Disease ReportVol. 52(11)
Memorial University of Newfoundland (CA), Newfoundland and Labrador Centre for Applied Health Research (CA)
Good health and well-being
Streptococcal Infections and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon